Nanotechnology Now

Our NanoNews Digest Sponsors

Heifer International

Wikipedia Affiliate Button

Home > Press > Raymor Received a Strategic Order from STRYKER

Abstract:
Unique powder to be used to create lasting biocompatible coatings for its new generation of
innovative orthopedic implants

Raymor Received a Strategic Order from STRYKER Corporation for its Biomedical Titanium Powder

Montreal, Quebec, Canada | March 23, 2005

Raymor Industries is proud to announce that its wholly-owned industrial subsidiary, AP&C Advanced Powders & Coatings Inc. (AP&C) has concluded a contract for Titanium powder production with STRYKER Corporation (NYSE: SYK). STRYKER will use this unique powder, given its sphericity and its purity, to create lasting biocompatible coatings for its new generation of innovative orthopedic implants.

The ultra-spherical titanium powder allows STRYKER to produce high quality orthopedic implants. Before issuing a purchase order to AP&C, Stryker conducted a worldwide search to find a powder which would provide optimal longevity and biocompatibility for its orthopedic implants.

Thanks to AP&C’s patented plasma atomization process, biomedical powders are of a high purity, with an exceptional sphericity. The spherical nature of the powder provides an evenly-distributed coating for artificial joints, thus allowing for the optimization of the coating porosity, which facilitates tissue growth.

“The STRYKER contract represents for AP&C a breakthrough in the biomedical sector with a large US company. STRYKER is one of the three global leaders in human orthopedic implants, and we are pleased to have been selected by them,” said Mr. Stéphane Robert, President of Raymor Industries.

“STRYKER received FDA (US Food & Drug Administration) approval for these innovative orthopedic implants using AP&C powder, enabling us to begin a long-term business relationship,” adds Mr. Robert.

According to Dr. Michel Drouet, Chief Scientist with AP&C, “At the beginning of the 90’s, I began development work on this plasma atomization process, which is unique in the world, at Hydro-Québec’s Shawinigan laboratories, in collaboration with Noranda. Thanks to AP&C, I am extremely happy to see all this research effort leading to commercialization in the orthopedic implant sector with a client as prestigious as STRYKER.”

“With this Titanium powder, other applications will be commercialized, including the metal injection molding of components for the aerospace sector. With our Plasma Atomization Process, we can in fact consider taking a foot-hold in other promising markets with other types of nano-sized and micron-sized metallic powders,” adds Dr. Drouet.

With other negotiations underway, AP&C foresees the installation of a second reactor in its facility, which could hold up to six units. The forecasted revenue from powder sales is in the order of $3.5 million per year, per reactor.

The world market for orthopedic implants was more than US$6.4 billion in 2002. Analysts from the renowned Freedonia Group predict markets of US$8.7 billion in 2007 and US$11.6 billion in 2012. The overall growth rate for this sector will be 6.2%. However, Freedonia Group and Frost & Sullivan both agree that this growth rate can increase significantly (up to 15% per year), given the potential removal of certain anti-inflammatory and pain medications from the market place by the FDA. As well, an aging population will likely have an impact on the orthopedic implant market growth rate.

####


About Raymor Industries
Raymor Industries (TSX-V:RAR) has for mission to be the largest Canadian developer of high technology and a producer/recycler of advanced materials and nanomaterials for high value-added applications. In November 2004, Raymor Industries created a wholly-owned, industrial subsidiary, AP&C Advanced Powders and Coatings, specializing in nanotechnology and advanced materials, and comprising four operational divisions: (1) metal and ceramic coatings, which largely targets aerospace, military, and mining applications; (2) spherical metallic powders, primarily used for biomedical and aerospace applications; (3) nanotechnology products, including nano-powders, nano-coatings, and carbon nanotubes for “the applications of tomorrow”; and (4) net-shape forming, a component manufacturing technique used for ballistic protection and other aerospace and military applications. Raymor holds the exclusive rights to 20 patents throughout the world.

For more information, visit www.raymor.com



Contact:
Raymond Fournel
Investor Relations
Tel: 514-932-3485
Fax: 514-932-3644
investor@raymor.com

Copyright © Raymor Industries

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

Investments/IPO's/Splits

Nanometrics to Participate in the 10th Annual CEO Investor Summit 2018: Accredited investor and publishing research analyst event held concurrently with SEMICON West and Intersolar 2018 in San Francisco June 28th, 2018

180 Degree Capital Corp. to Provide Live Remote Access to Its Annual Meeting of Shareholders on June 12, 2018 June 12th, 2018

Nanometrics Updates Time of Webcast at Stifel 2018 Cross Sector Insight Conference June 12th, 2018

Arrowhead Pharmaceuticals to Present at Upcoming June 2018 Conferences May 31st, 2018

Materials/Metamaterials

In borophene, boundaries are no barrier: Rice U., Northwestern researchers make and test atom-thick boron's unique domains July 17th, 2018

Barium ruthenate: A high-yield, easy-to-handle perovskite catalyst for the oxidation of sulfides July 13th, 2018

Carbon is the new black: Researchers use carbon nanotubes to develop clothing that can double as batteries July 10th, 2018

High-power electronics keep their cool with new heat-conducting crystals July 6th, 2018

Announcements

The relationship between charge density waves and superconductivity? It's complicated July 19th, 2018

Sirrus's Issued Patent Portfolio Continues To Accelerate July 18th, 2018

FEFU scientists reported on toxicity of carbon and silicon nanotubes and carbon nanofibers: Nanoparticles with a wide range of applying, including medicine, damage cells of microalgae Heterosigma akashivo badly. July 18th, 2018

In borophene, boundaries are no barrier: Rice U., Northwestern researchers make and test atom-thick boron's unique domains July 17th, 2018

NanoNews-Digest
The latest news from around the world, FREE



  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project